{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:16:35Z","timestamp":1791645395496,"version":"4.3.4"},"reference-count":111,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,19]]},"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by hyperglycemia, insulin resistance, and insufficient insulin secretion. Sarcopenia, as a new complication of diabetes, is characterized by the loss of muscle mass and the progressive decline of muscle strength and function in T2DM patients, which has a serious impact on the physical and mental health of patients. Insulin resistance, mitochondrial dysfunction, and chronic inflammation are common mechanisms of diabetes and sarcopenia. Reasonable exercise training, nutrition supplement, and drug intervention may improve the quality of life of patients with diabetes combined with sarcopenia. This article reviews the relevant factors and management measures of sarcopenia in T2DM patients, in order to achieve early detection, diagnosis, and intervention.<\/jats:p>","DOI":"10.1097\/md.0000000000037666","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T18:05:57Z","timestamp":1713549957000},"page":"e37666","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["A review on associated factors and management measures for sarcopenia in type 2 diabetes mellitus"],"prefix":"10.1097","volume":"103","author":[{"given":"Yi","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sui","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-8128","authenticated-orcid":false,"given":"Ping","family":"He","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition.","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00223-020-00742-y","article-title":"Type 2 diabetes mellitus is associated with increased risk of sarcopenia: a systematic review and meta-analysis.","volume":"107","author":"Anagnostis","year":"2020","journal-title":"Calcif Tissue Int"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.jamda.2016.07.007","article-title":"Frailty and sarcopenia as predictors of adverse health outcomes in persons with diabetes mellitus.","volume":"17","author":"Liccini","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people.","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jamda.2013.11.025","article-title":"Sarcopenia in Asia: consensus report of the Asian Working Group for sarcopenia.","volume":"15","author":"Chen","year":"2014","journal-title":"J Am Med Dir Assoc"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/ageing\/afz046","article-title":"Sarcopenia: revised European consensus on definition and diagnosis.","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1016\/S0140-6736(19)31138-9","article-title":"Sarcopenia.","volume":"393","author":"Cruz-Jentoft","year":"2019","journal-title":"Lancet"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3390\/cells11010160","article-title":"Multifactorial mechanism of sarcopenia and sarcopenic obesity. Role of physical exercise, microbiota and myokines.","volume":"11","author":"Bilski","year":"2022","journal-title":"Cells"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"100980","DOI":"10.1016\/j.arr.2019.100980","article-title":"Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis.","volume":"56","author":"Livshits","year":"2019","journal-title":"Ageing Res Rev"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.arr.2016.09.008","article-title":"Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis.","volume":"35","author":"Kalinkovich","year":"2017","journal-title":"Ageing Res Rev"},{"key":"R12-20250503","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S002966511500169X","article-title":"Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity.","volume":"74","author":"Wannamethee","year":"2015","journal-title":"Proc Nutr Soc"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.freeradbiomed.2018.08.035","article-title":"Sarcopenia, frailty and their prevention by exercise.","volume":"132","author":"Nascimento","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcsm.12411","article-title":"Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis.","volume":"10","author":"Yeung","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R15-20250503","doi-asserted-by":"crossref","first-page":"5475","DOI":"10.1016\/j.clnu.2021.09.036","article-title":"Malnutrition-sarcopenia syndrome and all-cause mortality in hospitalized older people.","volume":"40","author":"G\u00fcm\u00fc\u015fsoy","year":"2021","journal-title":"Clin Nutr"},{"key":"R16-20250503","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/wvn.12147","article-title":"Systematic literature review and meta-analysis of the association of sarcopenia with mortality.","volume":"13","author":"Chang","year":"2016","journal-title":"Worldviews Evid Based Nurs"},{"key":"R17-20250503","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jdiacomp.2017.05.003","article-title":"Frailty and sarcopenia\u2014newly emerging and high impact complications of diabetes.","volume":"31","author":"Sinclair","year":"2017","journal-title":"J Diabetes Complications"},{"key":"R18-20250503","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJM200406033502320","article-title":"Impaired mitochondrial activity and insulin-resistant offspring of patients with type 2 diabetes.","volume":"350","author":"M\u00f6hlig","year":"2004","journal-title":"N Engl J Med"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1210\/en.2003-0580","article-title":"Minireview: the adipocyte\u2014at the crossroads of energy homeostasis, inflammation, and atherosclerosis.","volume":"144","author":"Rajala","year":"2003","journal-title":"Endocrinology"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcjd.2015.09.004","article-title":"Diabetes and frailty: two converging conditions?","volume":"40","author":"Sinclair","year":"2016","journal-title":"Can J Diabetes"},{"key":"R21-20250503","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1046\/j.1532-5415.2003.51407.x","article-title":"Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study.","volume":"51","author":"Payette","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"R22-20250503","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1462-8902.2004.00339.x","article-title":"Intramyocellular lipids and insulin resistance.","volume":"6","author":"Machann","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12891-020-03236-y","article-title":"Association between sarcopenia and levels of growth hormone and insulin-like growth factor-1 in the elderly.","volume":"21","author":"Bian","year":"2020","journal-title":"BMC Musculoskelet Disord"},{"key":"R24-20250503","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1101\/gad.908001","article-title":"Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes.","volume":"15","author":"Fern\u00e1ndez","year":"2001","journal-title":"Genes Dev"},{"key":"R25-20250503","doi-asserted-by":"crossref","first-page":"166666","DOI":"10.1016\/j.bbadis.2023.166666","article-title":"Dysregulated autophagy: a key player in the pathophysiology of type 2 diabetes and its complications.","volume":"1869","author":"Sehrawat","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"R26-20250503","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cmet.2009.10.008","article-title":"Autophagy is required to maintain muscle mass.","volume":"10","author":"Masiero","year":"2009","journal-title":"Cell Metab"},{"key":"R27-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coph.2017.03.009","article-title":"Skeletal muscle autophagy and its role in sarcopenia and organismal aging.","volume":"34","author":"Jiao","year":"2017","journal-title":"Curr Opin Pharmacol"},{"key":"R28-20250503","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12877-022-02916-9","article-title":"Diabetes, sarcopenia and chronic kidney disease; the Screening for CKD among Older People across Europe (SCOPE) study.","volume":"22","author":"Formiga","year":"2022","journal-title":"BMC Geriatr"},{"key":"R29-20250503","doi-asserted-by":"crossref","first-page":"3950404","DOI":"10.1155\/2020\/3950404","article-title":"Risk factors for sarcopenia in the elderly with type 2 diabetes mellitus and the effect of metformin.","volume":"2020","author":"Chen","year":"2020","journal-title":"J Diabetes Res"},{"key":"R30-20250503","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/jdi.12908","article-title":"Importance of physical evaluation using skeletal muscle mass index and body fat percentage to prevent sarcopenia in elderly Japanese diabetes patients.","volume":"10","author":"Fukuoka","year":"2019","journal-title":"J Diabetes Investig"},{"key":"R31-20250503","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/jdi.13436","article-title":"High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: findings from the impact of diabetes mellitus on dynapenia study.","volume":"12","author":"Mori","year":"2021","journal-title":"J Diabetes Investig"},{"key":"R32-20250503","doi-asserted-by":"crossref","first-page":"104348","DOI":"10.1016\/j.archger.2021.104348","article-title":"Glucose regulation and grip strength in adults: findings from the Helsinki Birth Cohort Study.","volume":"94","author":"\u00c5str\u00f6m","year":"2021","journal-title":"Arch Gerontol Geriatr"},{"key":"R33-20250503","doi-asserted-by":"crossref","first-page":"110835","DOI":"10.1016\/j.exger.2020.110835","article-title":"Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus.","volume":"132","author":"de Freitas","year":"2020","journal-title":"Exp Gerontol"},{"key":"R34-20250503","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/clinem\/dgab884","article-title":"Prevalence and risk factors of sarcopenia in patients with diabetes: a meta-analysis.","volume":"107","author":"Feng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"R35-20250503","doi-asserted-by":"crossref","first-page":"e18708","DOI":"10.1097\/MD.0000000000018708","article-title":"A cross-sectional study: associations between sarcopenia and clinical characteristics of patients with type 2 diabetes.","volume":"99","author":"Cui","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"R36-20250503","doi-asserted-by":"crossref","first-page":"809.e9","DOI":"10.1016\/j.jamda.2017.06.012","article-title":"Association between sarcopenia and mild cognitive impairment using the Japanese version of the SARC-F in elderly patients with diabetes.","volume":"18","author":"Ida","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"R37-20250503","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/ggi.13461","article-title":"Relationship between sarcopenia and depression in older patients with diabetes: an investigation using the Japanese version of SARC-F.","volume":"18","author":"Ida","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"R38-20250503","doi-asserted-by":"crossref","first-page":"626","DOI":"10.5009\/gnl19126","article-title":"Sarcopenia is independently associated with the degree of liver fibrosis in patients with type 2 diabetes mellitus.","volume":"14","author":"Sung","year":"2020","journal-title":"Gut Liver"},{"key":"R39-20250503","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/jdi.13366","article-title":"Significance of body mass index for diagnosing sarcopenia is equivalent to slow gait speed in Japanese individuals with type 2 diabetes: cross-sectional study using outpatient clinical data.","volume":"12","author":"Nakanishi","year":"2021","journal-title":"J Diabetes Investig"},{"key":"R40-20250503","doi-asserted-by":"crossref","first-page":"782391","DOI":"10.3389\/fendo.2021.782391","article-title":"The association between diabetes mellitus and risk of sarcopenia: accumulated evidences from observational studies.","volume":"12","author":"Qiao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R41-20250503","doi-asserted-by":"crossref","first-page":"6973469","DOI":"10.1155\/2020\/6973469","article-title":"Metabolic and nutritional characteristics in middle-aged and elderly sarcopenia patients with type 2 diabetes.","volume":"2020","author":"He","year":"2020","journal-title":"J Diabetes Res"},{"key":"R42-20250503","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/ggi.14063","article-title":"Impact of sarcopenia on glycemic control and atherosclerosis in Japanese patients with type 2 diabetes: cross-sectional study using outpatient clinical data.","volume":"20","author":"Nakanishi","year":"2020","journal-title":"Geriatr Gerontol Int"},{"key":"R43-20250503","doi-asserted-by":"crossref","first-page":"107926","DOI":"10.1016\/j.jdiacomp.2021.107926","article-title":"Influence of glucose, insulin fluctuation, and glycosylated hemoglobin on the outcome of sarcopenia in patients with type 2 diabetes mellitus.","volume":"35","author":"Lin","year":"2021","journal-title":"J Diabetes Complications"},{"key":"R44-20250503","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/jdi.13070","article-title":"Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus.","volume":"10","author":"Sugimoto","year":"2019","journal-title":"J Diabetes Investig"},{"key":"R45-20250503","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.diabres.2016.06.023","article-title":"Sarcopenia associated with renal function in the patients with type 2 diabetes.","volume":"118","author":"Yang","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"R46-20250503","first-page":"102","article-title":"Sarcopenia in diabetic nephropathy: a cross-sectional study.","volume":"56","author":"\u00c7eliker","year":"2018","journal-title":"Rom J Intern Med"},{"key":"R47-20250503","doi-asserted-by":"crossref","first-page":"1365189","DOI":"10.1155\/2019\/1365189","article-title":"Association between sarcopenia and renal function in patients with diabetes: a systematic review and meta-analysis.","volume":"2019","author":"Ida","year":"2019","journal-title":"J Diabetes Res"},{"key":"R48-20250503","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pcd.2019.04.007","article-title":"Relationship between diabetic neuropathy and sarcopenia.","volume":"13","author":"Yasemin","year":"2019","journal-title":"Prim Care Diabetes"},{"key":"R49-20250503","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jdiacomp.2019.04.007","article-title":"Association between deterioration in muscle strength and peripheral neuropathy in people with diabetes.","volume":"33","author":"Oh","year":"2019","journal-title":"J Diabetes Complications"},{"key":"R50-20250503","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/1753-0407.13216","article-title":"Combined association of skeletal muscle mass and grip strength with cardiovascular diseases in patients with type 2 diabetes.","volume":"13","author":"Park","year":"2021","journal-title":"J Diabetes"},{"key":"R51-20250503","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.2147\/DMSO.S326195","article-title":"Relationship between skeletal muscle mass to visceral fat area ratio and cardiovascular risk in type 2 diabetes.","volume":"14","author":"Liu","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R52-20250503","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.diabet.2019.10.004","article-title":"Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes.","volume":"46","author":"Seo","year":"2020","journal-title":"Diabetes Metab"},{"key":"R53-20250503","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.3390\/jcm9072133","article-title":"Walking speed is the sole determinant criterion of sarcopenia of mild cognitive impairment in Japanese elderly patients with type 2 diabetes mellitus.","volume":"9","author":"Machii","year":"2020","journal-title":"J Clin Med"},{"key":"R54-20250503","doi-asserted-by":"crossref","first-page":"108258","DOI":"10.1016\/j.jdiacomp.2022.108258","article-title":"Decline in skeletal muscle mass is associated with cognitive decline in type 2 diabetes mellitus.","volume":"36","author":"Low","year":"2022","journal-title":"J Diabetes Complications"},{"key":"R55-20250503","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.3390\/nu13124499","article-title":"Exercise and nutrition impact on osteoporosis and sarcopenia-the incidence of osteosarcopenia: a narrative review.","volume":"13","author":"Papadopoulou","year":"2021","journal-title":"Nutrients"},{"key":"R56-20250503","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1186\/s12877-021-02642-8","article-title":"Effects of different exercise training modes on muscle strength and physical performance in older people with sarcopenia: a systematic review and meta-analysis.","volume":"21","author":"Lu","year":"2021","journal-title":"BMC Geriatr"},{"key":"R57-20250503","doi-asserted-by":"crossref","first-page":"afac003","DOI":"10.1093\/ageing\/afac003","article-title":"Resistance exercise as a treatment for sarcopenia: prescription and delivery.","volume":"51","author":"Hurst","year":"2022","journal-title":"Age Ageing"},{"key":"R58-20250503","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1249\/MSS.0b013e3181eeb61c","article-title":"Exercise and type 2 diabetes: American College of Sports Medicine and the American Diabetes Association: joint position statement. Exercise and type 2 diabetes.","volume":"42","author":"Colberg","year":"2010","journal-title":"Med Sci Sports Exerc"},{"key":"R59-20250503","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1249\/MSS.0000000000000242","article-title":"Aerobic and strength training in concomitant metabolic syndrome and type 2 diabetes.","volume":"46","author":"Earnest","year":"2014","journal-title":"Med Sci Sports Exerc"},{"key":"R60-20250503","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12966-018-0703-3","article-title":"Exercise training modalities in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis.","volume":"15","author":"Pan","year":"2018","journal-title":"Int J Behav Nutr Phys Act"},{"key":"R61-20250503","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12933-018-0711-2","article-title":"Exercise training and endothelial function in patients with type 2 diabetes: a meta-analysis.","volume":"17","author":"Qiu","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"R62-20250503","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/jama.2011.576","article-title":"Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis.","volume":"305","author":"Umpierre","year":"2011","journal-title":"JAMA"},{"key":"R63-20250503","doi-asserted-by":"crossref","first-page":"6978128","DOI":"10.1155\/2020\/6978128","article-title":"The effects of combined exercise training (resistance-aerobic) on serum kinesin and physical function in type 2 diabetes patients with diabetic peripheral neuropathy (randomized controlled trials).","volume":"2020","author":"Seyedizadeh","year":"2020","journal-title":"J Diabetes Res"},{"key":"R64-20250503","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jdiacomp.2012.05.007","article-title":"The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy.","volume":"26","author":"Kluding","year":"2012","journal-title":"J Diabetes Complications"},{"key":"R65-20250503","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12933-019-0840-2","article-title":"Effects of combined training with different intensities on vascular health in patients with type 2 diabetes: a 1-year randomized controlled trial.","volume":"18","author":"Magalh\u00e3es","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"R66-20250503","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ggi.13820","article-title":"Assessing the association between optimal energy intake and all-cause mortality in older patients with diabetes mellitus using the Japanese elderly diabetes intervention trial.","volume":"20","author":"Omura","year":"2020","journal-title":"Geriatr Gerontol Int"},{"key":"R67-20250503","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clnu.2018.05.024","article-title":"ESPEN guideline on clinical nutrition and hydration in geriatrics.","volume":"38","author":"Volkert","year":"2019","journal-title":"Clin Nutr"},{"key":"R68-20250503","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/advances\/nmy065","article-title":"The impact of dairy protein intake on muscle mass, muscle strength, and physical performance in middle-aged to older adults with or without existing sarcopenia: a systematic review and meta-analysis.","volume":"10","author":"Hanach","year":"2019","journal-title":"Adv Nutr"},{"key":"R69-20250503","doi-asserted-by":"crossref","first-page":"1571S","DOI":"10.1093\/ajcn\/87.5.1571S","article-title":"Protein in optimal health: heart disease and type 2 diabetes.","volume":"87","author":"Layman","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R70-20250503","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/jdi.12164","article-title":"Appropriate physical activity and dietary intake achieve optimal metabolic control in older type 2 diabetes patients.","volume":"5","author":"Huang","year":"2014","journal-title":"J Diabetes Investig"},{"key":"R71-20250503","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40520-016-0715-2","article-title":"The \u201cSarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies\u201d (SPRINTT) randomized controlled trial: design and methods.","volume":"29","author":"Landi","year":"2017","journal-title":"Aging Clin Exp Res"},{"key":"R72-20250503","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.maturitas.2017.02.016","article-title":"Low vitamin D levels increase the risk of type 2 diabetes in older adults: a systematic review and meta-analysis.","volume":"100","author":"Lucato","year":"2017","journal-title":"Maturitas"},{"key":"R73-20250503","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/ageing\/afp109","article-title":"Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438).","volume":"38","author":"Avenell","year":"2009","journal-title":"Age Ageing"},{"key":"R74-20250503","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.plefa.2018.03.010","article-title":"Supplementation with eicosapentaenoic acid and docosahexaenoic acid reduces high levels of circulating proinflammatory cytokines in aging adults: a randomized, controlled study.","volume":"132","author":"Tan","year":"2018","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"R75-20250503","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.arr.2018.05.004","article-title":"Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: a systematic review and meta-analysis.","volume":"46","author":"Custodero","year":"2018","journal-title":"Ageing Res Rev"},{"key":"R76-20250503","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1080\/10408398.2015.1130016","article-title":"Polyunsaturated fatty acids and type 2 diabetes: impact on the glycemic control mechanism.","volume":"57","author":"Coelho","year":"2017","journal-title":"Crit Rev Food Sci Nutr"},{"key":"R77-20250503","doi-asserted-by":"crossref","first-page":"116539","DOI":"10.1016\/j.bone.2022.116539","article-title":"Lipid metabolism in sarcopenia.","volume":"164","author":"Al Saedi","year":"2022","journal-title":"Bone"},{"key":"R78-20250503","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3390\/nu10081067","article-title":"Impact of a Mediterranean dietary pattern and its components on cardiovascular risk factors, glucose control, and body weight in people with type 2 diabetes: a real-life study.","volume":"10","author":"Vitale","year":"2018","journal-title":"Nutrients"},{"key":"R79-20250503","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/ajcn\/nqac154","article-title":"Effect of a ketogenic diet versus Mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the interventional Keto-Med randomized crossover trial.","volume":"116","author":"Gardner","year":"2022","journal-title":"Am J Clin Nutr"},{"key":"R80-20250503","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s12603-017-0993-1","article-title":"Mediterranean diet and musculoskeletal-functional outcomes in community-dwelling older people: a systematic review and meta-analysis.","volume":"22","author":"Silva","year":"2018","journal-title":"J Nutr Health Aging"},{"key":"R81-20250503","doi-asserted-by":"crossref","first-page":"101395","DOI":"10.1016\/j.arr.2021.101395","article-title":"Cross-sectional and longitudinal associations between adherence to Mediterranean diet with physical performance and cognitive function in older adults: a systematic review and meta-analysis.","volume":"70","author":"Coelho-J\u00fanior","year":"2021","journal-title":"Ageing Res Rev"},{"key":"R82-20250503","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3390\/nu15051104","article-title":"Mediterranean diet and sarcopenia features in apparently healthy adults over 65 years: a systematic review.","volume":"15","author":"Papadopoulou","year":"2023","journal-title":"Nutrients"},{"key":"R83-20250503","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jcsm.12833","article-title":"Metformin induces muscle atrophy by transcriptional regulation of myostatin via HDAC6 and FoxO3a.","volume":"13","author":"Kang","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R84-20250503","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.3390\/nu12113367","article-title":"Nutrition management in older adults with diabetes: a review on the importance of shifting prevention strategies from metabolic syndrome to frailty.","volume":"12","author":"Tamura","year":"2020","journal-title":"Nutrients"},{"key":"R85-20250503","doi-asserted-by":"crossref","first-page":"e00028","DOI":"10.1002\/prp2.28","article-title":"Database search of spontaneous reports and pharmacological investigations on the sulfonylureas and glinides-induced atrophy in skeletal muscle.","volume":"2","author":"Mele","year":"2014","journal-title":"Pharmacol Res Perspect"},{"key":"R86-20250503","doi-asserted-by":"crossref","first-page":"122","DOI":"10.14740\/jocmr4078","article-title":"Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin on muscle mass and the muscle\/fat ratio in patients with type 2 diabetes.","volume":"12","author":"Ishii","year":"2020","journal-title":"J Clin Med Res"},{"key":"R87-20250503","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.2337\/dc11-1032","article-title":"Insulin sensitizers may attenuate lean mass loss in older men with diabetes.","volume":"34","author":"Lee","year":"2011","journal-title":"Diabetes Care"},{"key":"R88-20250503","doi-asserted-by":"crossref","first-page":"E65","DOI":"10.1152\/ajpendo.00505.2018","article-title":"Effect of PPAR\u03b3 agonist on aerobic exercise capacity in relation to body fat distribution in men with type 2 diabetes mellitus and coronary artery disease: a 1-yr randomized study.","volume":"317","author":"Bastien","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R89-20250503","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/dme.12512","article-title":"Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial.","volume":"31","author":"Punthakee","year":"2014","journal-title":"Diabet Med"},{"key":"R90-20250503","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/oby.2010.327","article-title":"The effect of pioglitazone and resistance training on body composition in older men and women undergoing hypocaloric weight loss.","volume":"19","author":"Shea","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"R91-20250503","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jamda.2016.04.016","article-title":"Sarcopenia in elderly diabetic patients: role of dipeptidyl peptidase 4 inhibitors.","volume":"17","author":"Rizzo","year":"2016","journal-title":"J Am Med Dir Assoc"},{"key":"R92-20250503","doi-asserted-by":"crossref","first-page":"111832","DOI":"10.1016\/j.exger.2022.111832","article-title":"DPP4 inhibitors as a potential therapeutic option for sarcopenia: a 6-month follow-up study in diabetic older patients.","volume":"164","author":"Sencan","year":"2022","journal-title":"Exp Gerontol"},{"key":"R93-20250503","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2957","article-title":"Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes.","volume":"34","author":"Bouchi","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"R94-20250503","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/jdi.12851","article-title":"Sodium-glucose cotransporter 2 inhibitor-induced changes in body composition and simultaneous changes in metabolic profile: 52-week prospective LIGHT (Luseogliflozin: the components of weight loss in Japanese patients with type 2 diabetes mellitus) study.","volume":"10","author":"Sasaki","year":"2019","journal-title":"J Diabetes Investig"},{"key":"R95-20250503","doi-asserted-by":"crossref","first-page":"6470137","DOI":"10.1155\/2018\/6470137","article-title":"Effect of tofogliflozin on body composition and glycemic control in Japanese subjects with type 2 diabetes mellitus.","volume":"2018","author":"Kamei","year":"2018","journal-title":"J Diabetes Res"},{"key":"R96-20250503","doi-asserted-by":"crossref","first-page":"467","DOI":"10.5551\/jat.40873","article-title":"Dapagliflozin reduces fat mass without affecting muscle mass in type 2 diabetes.","volume":"25","author":"Sugiyama","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"R97-20250503","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13340-021-00512-7","article-title":"Two-year administration of sodium-glucose co-transporter 2 inhibitor brought about marked reduction of body fat independent of skeletal muscle amount or glycemic improvement in Japanese patients with type 2 diabetes.","volume":"13","author":"Sakamoto","year":"2022","journal-title":"Diabetol Int"},{"key":"R98-20250503","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1475-2840-13-36","article-title":"Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients.","volume":"13","author":"Li","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"R99-20250503","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jdiacomp.2018.05.018","article-title":"The effect of dulaglutide on body composition in type 2 diabetes mellitus patients on hemodialysis.","volume":"32","author":"Yajima","year":"2018","journal-title":"J Diabetes Complications"},{"key":"R100-20250503","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.diabres.2014.01.019","article-title":"Beneficial effects of liraglutide on adipocytokines, insulin sensitivity parameters and cardiovascular risk biomarkers in patients with type 2 diabetes: a prospective study.","volume":"104","author":"D\u00edaz-Soto","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"R101-20250503","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s40520-015-0525-y","article-title":"Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study.","volume":"28","author":"Perna","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"R102-20250503","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00223-017-0251-x","article-title":"Insulin treatment attenuates decline of muscle mass in Japanese patients with type 2 diabetes.","volume":"101","author":"Bouchi","year":"2017","journal-title":"Calcif Tissue Int"},{"key":"R103-20250503","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jamda.2020.11.003","article-title":"Glycemic control and insulin improve muscle mass and gait speed in type 2 diabetes: the MUSCLES-DM study.","volume":"22","author":"Sugimoto","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"R104-20250503","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1002\/jcsm.12579","article-title":"Pathophysiological mechanisms of statin-associated myopathies: possible role of the ubiquitin-proteasome system.","volume":"11","author":"Sahebkar","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"R105-20250503","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: a systematic review.","volume":"49","author":"Marcoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R106-20250503","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jvs.2021.04.054","article-title":"Statin use, development of sarcopenia, and long-term survival after endovascular aortic repair.","volume":"74","author":"Lindstr\u00f6m","year":"2021","journal-title":"J Vasc Surg"},{"key":"R107-20250503","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.3390\/ijerph17051494","article-title":"Hyperlipidemia and statins use for the risk of new diagnosed sarcopenia in patients with chronic kidney: a population-based study.","volume":"17","author":"Lin","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R108-20250503","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12872-022-02804-5","article-title":"Statins are associated with reduced likelihood of sarcopenia in a sample of heart failure outpatients: a cross-sectional study.","volume":"22","author":"Valdiviesso","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"R109-20250503","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/jcpt.13540","article-title":"Angiotensin II receptor blocker and statin combination therapy associated with higher skeletal muscle index in patients with cardiovascular disease: a retrospective study.","volume":"47","author":"Harada","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"R110-20250503","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12603-016-0743-9","article-title":"Effectiveness of cardiac rehabilitation for prevention and treatment of sarcopenia in patients with cardiovascular disease\u2014a retrospective cross-sectional analysis.","volume":"21","author":"Harada","year":"2017","journal-title":"J Nutr Health Aging"},{"key":"R111-20250503","doi-asserted-by":"crossref","first-page":"872745","DOI":"10.3389\/fphys.2022.872745","article-title":"Potential benefits of combined statin and metformin therapy on resistance training response in older individuals.","volume":"13","author":"Long","year":"2022","journal-title":"Front Physiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037666","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:09:27Z","timestamp":1746317367000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000037666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":111,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000037666","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]}}}